NCT07162597View on ClinicalTrials.gov

A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

June 30, 2028

Conditions
Atrial Fibrillation (Paroxysmal)
Interventions
DEVICE

Pulsed Field Ablation

Pulsed Field Ablation

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Shanghai Zhongshan Hospital

OTHER

NCT07162597 - A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava | Biotech Hunter | Biotech Hunter